At the news
? BEARISHIMPACT 7/10 8-K filed Nov 2, 2026 at 09:21 ET
Karyopharm Therapeutics filed for Chapter 11 bankruptcy and entered into a Restructuring Support Agreement with lenders and noteholders for a merger with Ayrmid Ltd. The company states existing equity holders will receive no distribution and expects a complete loss on their investment. The transaction is expected to close in Q1 2027.
- Karyopharm filed voluntary Chapter 11 petitions in the Southern District of Texas on November 2, 2026.
- The company entered into a Restructuring Support Agreement providing for a merger with Ayrmid Ltd.
- Existing common stock and convertible preferred stock holders will receive no payment or distribution.
- The company expects existing equity securities will have no value and holders will experience a complete loss.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access